NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) | PAR 19 296

Opportunity Information: Apply for PAR 19 296

The NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed), Funding Opportunity Number PAR-19-296, is a discretionary NIH grant program in the health funding category (CFDA 93.855) run by the National Institute of Allergy and Infectious Diseases (NIAID). Its core purpose is to back post-doctoral and early stage investigators who show exceptional creativity and who want to pursue bold, highly innovative research ideas that could reshape understanding or approaches in areas that matter to NIAID. The program is built for researchers proposing fresh directions rather than incremental next steps, with an emphasis on projects that have the potential to make a major impact on broad and important biomedical research problems aligned with NIAID priorities. As the title indicates, clinical trials are not allowed under this specific DP2 opportunity.

The opportunity is open to a wide range of applicant organizations, reflecting NIH's broad eligibility rules for many research grant programs. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; and public housing authorities/Indian housing authorities. Higher education institutions may apply, including public and state-controlled universities as well as private institutions of higher education. A variety of nonprofit organizations are eligible, including 501(c)(3) nonprofits and nonprofits without 501(c)(3) status, as long as they are not applying as institutions of higher education. For-profit organizations (other than small businesses) and small businesses are also listed as eligible, along with Native American tribal governments (federally recognized) and Native American tribal organizations that are not federally recognized tribal governments. In addition to these standard categories, the announcement explicitly welcomes applications and participation from organizations serving historically underrepresented communities, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). It also notes eligibility for faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions, reinforcing that the program is intended to be accessible across many institutional types.

On the international side, the eligibility language draws an important boundary. Non-domestic (non-U.S.) entities and non-domestic (non-U.S.) institutions are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, meaning a U.S.-based applicant can include certain foreign activities or collaborations if they meet NIH requirements and are justified within the project, even though a foreign institution cannot serve as the primary applicant.

From the funding details provided, the award ceiling is listed as $300,000, and the opportunity is structured as a grant. The original closing date shown for the referenced cycle is August 14, 2020, and the record creation date is June 7, 2019. While the listing includes a field for expected awards, the number is not specified in the provided data. Overall, this opportunity is best understood as a high-impact innovation program aimed at accelerating the careers of unusually creative early investigators by giving them support to pursue ambitious, potentially field-shifting ideas within NIAID's mission space, with the key constraint that proposed work must not include clinical trials.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855.
• This funding opportunity was created on 2019-06-07.
• Applicants must submit their applications by 2020-08-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $300,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 19 296

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: